Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added in place of Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedPublications section added a new PubMed entry for a 2026 Nat Commun article, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded a glossary toggle and updated site metadata labels (including Last Update Submitted that Met QC Criteria) with a revision to v3.4.0, while removing the older QC label and adjusting capitalization (No FEAR Act Data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations are consolidated into a single Locations section listing sites in Arizona, Colorado, Florida, Illinois, Iowa, Massachusetts, Michigan, Missouri, New Jersey, New York, Texas, Utah, Wisconsin, and Victoria; the per-location subsections were removed, and the update is labeled Revision: v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedRevision: v3.3.2 has been added and v3.2.0 removed.SummaryDifference0.0%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.